Description of Research Expertise:
Block A.: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. New Engl J Med
Goodman W: The calcimimetic agent amg 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13 : 1017-1024,2002.
Berns JS, Rudnick MR, Cohen RM, Bower JD: Effect of normal versus anemic hematocrit on ambulatory blood pressures in epoetin-treated hemodialysis patients with cardiac disease. Kidney Int (56): 153-260,1999.
Rudnick MR, Berns JS: Contrast media in dialysis patients: Should we be more concerned? Sem Dialysis (11): 3-6,1998.
Berns JS, Rudnick MR: Antiviral Agents. In: DeBroe ME, Porter GA, Bennett WM, Verpooten GA, eds. Clinical Nephrotoxins. Renal injury from drugs and chemicals. : 175-186,1998.
Ermer JE, Boni JP, Cevallos WH, DeCleene S, Burghart P, Rudnick MR, Fruncello RJ, Berns JS: Bromfenac disposition in patients with impaired renal function. Clin Pharmaco Ther. 61 : 312-18,1997.
Berns JS, Cohen RM, Silverman M: Acute renal failure due to indinavir crystalluria and nephrolithiasis: Report of two cases. Am J Kidney Dis 30 : 1997.
Berns JS, Rudnick MR: Anti-infectious agents-antivirals. In: Bennett WM, DeBroe ME, Porter GA, Verpooten GA, eds. Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals. : 1997.
Rudnick MR, Berns JS, Cohen RM: Contrast media-associated nephrotoxicity. Sem Nephrol 17 : 15-26,1997.
Cohen RM, Feldman GM: The balance of acid, base and charge in health and disease. Kidney Int 52 : 287-293,1997.